Stockreport

HSA approves GSK's Arexvy, the world's first respiratory syncytial virus (RSV) vaccine for older adults [Yahoo! Finance]

Agenus Inc.  (AGEN) 
Last agenus inc. earnings: 3/12 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: agenusbio.com/investors
PDF disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. [2] Arexvy is 94.6% efficacious in preventing LRTD caused by RSV i [Read more]